Temat: "Disease-Free Survival" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: VEGFC Gene Expression Is Associated with Tumor Progression and Disease-Free Survival in Cutaneous Squamous Cell Carcinoma.
Autorzy:: García-Pérez O; Research Unit, Hospital Universitario Nuestra Señora de Candelaria, 38010 Santa Cruz de Tenerife, Spain.; Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias (IUETSPC), Universidad de La Laguna, 38200 San Cristóbal de La Laguna, Spain.
Melgar-Vilaplana L; Pathology Department, Hospital Universitario Nuestra Señora de Candelaria, Ctra. Gral. del Rosario, 145, 38010 Santa Cruz de Tenerife, Spain.
Sifaoui I; Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias (IUETSPC), Universidad de La Laguna, 38200 San Cristóbal de La Laguna, Spain.
Śmietańska A; Faculty of Pharmacy, Medical University Wroclaw, 50-556 Wroclaw, Poland.
Córdoba-Lanús E; Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias (IUETSPC), Universidad de La Laguna, 38200 San Cristóbal de La Laguna, Spain.; Centro de Investigación Biomédica en Red, CIBERINFEC, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Fernández-de-Misa R; Research Unit, Hospital Universitario Nuestra Señora de Candelaria, 38010 Santa Cruz de Tenerife, Spain.; Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias (IUETSPC), Universidad de La Laguna, 38200 San Cristóbal de La Laguna, Spain.; Dermatology Department, Hospital Universitario Nuestra Señora de Candelaria, Ctra. Gral. del Rosario, 145, 38010 Santa Cruz de Tenerife, Spain.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 27; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 27.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Squamous Cell*/genetics
Skin Neoplasms*/genetics
Humans ; Disease-Free Survival ; Gene Expression ; Vascular Endothelial Growth Factor C/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Evaluation of survival outcomes and prognostic factors of carcinoma anal canal at a tertiary cancer center.
Autorzy:: Mishra H; Department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, BHU, Varanasi, Uttar Pradesh, India.
Mishra R; Department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, BHU, Varanasi, Uttar Pradesh, India.
Singh A; Department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, BHU, Varanasi, Uttar Pradesh, India.
Mandal A; Department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, BHU, Varanasi, Uttar Pradesh, India.
Singh TB; Department of Biostatistics, Institute of Medical Sciences, BHU, Varanasi, Uttar Pradesh, India.
Asthana AK; Department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, BHU, Varanasi, Uttar Pradesh, India.; Pokaż więcej
Źródło:: Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Oct 01; Vol. 19 (7), pp. 1998-2004. Date of Electronic Publication: 2023 Apr 27.
Typ publikacji:: Journal Article
MeSH Terms:: Anal Canal*
Carcinoma, Squamous Cell*/therapy
Humans ; Middle Aged ; Prognosis ; Disease-Free Survival ; Progression-Free Survival

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Preliminary clinical outcomes of head and neck squamous cell carcinoma treated with particle beam radiation therapy.
Autorzy:: Huang Q; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, 201321, China.; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.
Hu J; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.
Hu W; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.
Gao J; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.
Yang J; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.
Qiu X; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.
Zhang H; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.
Lu JJ; Department of Radiation Oncology, Proton and Heavy Ion Center, Heyou International Hospital, Foshan, China.
Kong L; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (11), pp. 12128-12138. Date of Electronic Publication: 2023 Apr 11.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Head and Neck Neoplasms*/radiotherapy
Carcinoma, Squamous Cell*/pathology
Humans ; Squamous Cell Carcinoma of Head and Neck/radiotherapy ; Retrospective Studies ; Quality of Life ; Disease-Free Survival ; China ; Neoplasm Recurrence, Local/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Chemoradiotherapy with paclitaxel liposome plus cisplatin for locally advanced esophageal squamous cell carcinoma: A retrospective analysis.
Autorzy:: Yi Q; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Radiation Oncology, Nantong Tumor Hospital, Affiliated Tumor Hospital of Nantong University, Nantong, China.
Liu C; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Radiation Oncology, Suzhou Dushu Lake Hospital, Dushu Lake Hospital Affiliated to Soochow University, Medical Center of Soochow University, Suzhou, China.
Cui Y; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Radiation Oncology, Jinhua Hospital, Zhejiang University School of Medicine, Jinhua Municipal Central Hospital, Zhejiang, China.
Yang Y; Department of Radiation Oncology, Nantong Tumor Hospital, Affiliated Tumor Hospital of Nantong University, Nantong, China.
Li Y; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Fan X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Wu K; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Mar; Vol. 12 (6), pp. 6477-6487. Date of Electronic Publication: 2022 Nov 22.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Esophageal Squamous Cell Carcinoma*/drug therapy
Esophageal Neoplasms*/drug therapy
Carcinoma, Squamous Cell*
Humans ; Cisplatin/therapeutic use ; Retrospective Studies ; Liposomes ; Disease-Free Survival ; Paclitaxel ; Chemoradiotherapy/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Esophageal cancer: Outcome and potential benefit of esophagectomy in elderly patients.
Autorzy:: Laurent A; Department of Digestive Surgery, Faculty of Medicine (ULB), Erasme University Hospital Center, Brussels, Belgium.
Marechal R; Department of Gastroenterology, University Hospital Center of Tivoli, La louvière, Belgium.
Farinella E; Department of Digestive Surgery, Faculty of Medicine (ULB), Erasme University Hospital Center, Brussels, Belgium.
Bouazza F; Department of Digestive Surgical Oncology, Faculty of Medicine (ULB), Institut Jules Bordet, Brussels, Belgium.
Charaf Y; Department of Digestive Surgery, Faculty of Medicine (ULB), Erasme University Hospital Center, Brussels, Belgium.
Gay F; Department of Gastroenterology and Digestive Oncology, Faculty of Medicine (ULB), Erasme University Hospital Center, Brussels, Belgium.
Van Laethem JL; Department of Gastroenterology and Digestive Oncology, Faculty of Medicine (ULB), Erasme University Hospital Center, Brussels, Belgium.
Gonsette K; Department of Anesthesiology, Faculty of Medicine (ULB), Erasme University Hospital Center, Brussels, Belgium.
El Nakadi I; Department of Digestive Surgery, Faculty of Medicine (ULB), Erasme University Hospital Center, Brussels, Belgium.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2022 Oct; Vol. 13 (19), pp. 2699-2710. Date of Electronic Publication: 2022 Aug 24.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Squamous Cell*/pathology
Esophageal Neoplasms*/pathology
Aged ; Disease-Free Survival ; Esophagectomy ; Humans ; Neoadjuvant Therapy ; Retrospective Studies ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Stage migration and treatment outcome in carcinoma tongue - A comparison of seventh and eighth AJCC pathological staging systems.
Autorzy:: George R; Department of Pathology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.
Prakasan A; Department of Radiation Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.
Anila KR; Department of Pathology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.
Jagathnath Krishna KM; Department of Cancer Epidemiology and Biostatistics, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.
Iype EM; Department of Surgical Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.
Jayasree K; Department of Pathology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.
Ramadas K; Department of Radiation Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.; Pokaż więcej
Źródło:: Indian journal of cancer [Indian J Cancer] 2022 Oct-Dec; Vol. 59 (4), pp. 584-590.
Typ publikacji:: Journal Article
MeSH Terms:: Tongue Neoplasms*/surgery
Carcinoma, Squamous Cell*/surgery
Humans ; Treatment Outcome ; Disease-Free Survival ; Tongue

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Survival study in early stages of glottis cancer, stratified by treatment.
Autorzy:: Lois-Ortega Y; Department of Otorhinolaryngology, Obispo Polanco Hospital, Teruel, Spain.
García-Curdi F; Department of Otorhinolaryngology, Obispo Polanco Hospital, Teruel, Spain.
Vallés-Varela H; Department of Otorhinolaryngology, Lozano Blesa University Clinical Hospital, Zaragoza, Spain.
Muniesa-Del Campo A; Faculty of Veterinary Sciences, Department of Animal Pathology, University of Zaragoza, Zaragoza, Spain.; Pokaż więcej
Źródło:: Acta oto-laryngologica [Acta Otolaryngol] 2022 Jul-Aug; Vol. 142 (7-8), pp. 627-633. Date of Electronic Publication: 2022 Aug 22.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Squamous Cell*/pathology
Carcinoma, Squamous Cell*/surgery
Laryngeal Neoplasms*/pathology
Laryngeal Neoplasms*/surgery
Laser Therapy*/methods
Carbon Dioxide ; Disease-Free Survival ; Glottis/pathology ; Glottis/surgery ; Humans ; Microsurgery/methods ; Neoplasm Staging ; Retrospective Studies ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Folate Receptor 4-Expressing T cell Is Associated with Disease-Free Survival in Patients with Esophageal Squamous Cell Carcinoma.
Autorzy:: Zhang X; Research Center, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.; Hebei Provincial Key Laboratory of Tumor Microenvironment and Drug Resistance, Hebei Medical University, Shijiazhuang 050017, China.
Zhao Q; Department of Thoracic Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
Cao M; Department of Breast Cancer Center, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
Li X; Cancer Institute, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
Chen X; Department of Thoracic Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
He M; Department of Thoracic Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
Liu Y; Hebei Provincial Key Laboratory of Tumor Microenvironment and Drug Resistance, Hebei Medical University, Shijiazhuang 050017, China.; Department of Breast Cancer Center, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
Zhao J; Hebei Provincial Key Laboratory of Tumor Microenvironment and Drug Resistance, Hebei Medical University, Shijiazhuang 050017, China.; Department of Thoracic Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.; Pokaż więcej
Źródło:: Disease markers [Dis Markers] 2022 Jun 15; Vol. 2022, pp. 4351949. Date of Electronic Publication: 2022 Jun 15 (Print Publication: 2022).
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Squamous Cell*/drug therapy
Carcinoma, Squamous Cell*/therapy
Esophageal Neoplasms*/pathology
Esophageal Squamous Cell Carcinoma*/therapy
Disease-Free Survival ; Female ; Folic Acid ; Humans ; Prognosis ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Hormone receptors AR, ER, PR and growth factor receptor Her-2 expression in oral squamous cell carcinoma: Correlation with overall survival, disease-free survival and 10-year survival in a high-risk population.
Autorzy:: Adnan Y; Office of Academia and Research in Surgery, Department of Surgery, Aga Khan University Hospital, Karachi, Pakistan.; Department of Biosciences, Faculty of Life Sciences, Shaheed Zulfikar Ali Bhutto Institute of Science and Technology, Karachi, Pakistan.
Ali SMA; Office of Academia and Research in Surgery, Department of Surgery, Aga Khan University Hospital, Karachi, Pakistan.
Awan MS; Section of Otolaryngology-Head and Neck Surgery, Department of Surgery, Aga Khan University Hospital, Karachi, Pakistan.
Idress R; Section of Histopathology, Department of Pathology and Laboratory Medicines, Aga Khan University Hospital, Karachi, Pakistan.
Awan MO; Medical College, Aga Khan University Hospital, Karachi, Pakistan.
Farooqui HA; Office of Academia and Research in Surgery, Department of Surgery, Aga Khan University Hospital, Karachi, Pakistan.
Kayani HA; Department of Biosciences, Faculty of Life Sciences, Shaheed Zulfikar Ali Bhutto Institute of Science and Technology, Karachi, Pakistan.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 May 11; Vol. 17 (5), pp. e0267300. Date of Electronic Publication: 2022 May 11 (Print Publication: 2022).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*
Mouth Neoplasms*/pathology
Biomarkers, Tumor/metabolism ; Disease-Free Survival ; Female ; Hormones ; Humans ; Male ; Prognosis ; Squamous Cell Carcinoma of Head and Neck

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: The impact of tobacco smoking on survival of patients with oral squamous cell carcinoma: a population-based retrospective study.
Autorzy:: Andersen AO; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Jensen JS; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Jakobsen KK; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Stampe H; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Nielsen KJ; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Wessel I; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Christensen A; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Andersen E; Department of Oncology, Herlev-Gentofte University Hospital, Capital Region, Denmark.
Friborg J; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Grønhøj C; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
von Buchwald C; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Pokaż więcej
Źródło:: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 Apr; Vol. 61 (4), pp. 449-458. Date of Electronic Publication: 2022 Feb 04.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Squamous Cell*/epidemiology
Carcinoma, Squamous Cell*/etiology
Head and Neck Neoplasms*
Mouth Neoplasms*/epidemiology
Mouth Neoplasms*/etiology
Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Squamous Cell Carcinoma of Head and Neck ; Tobacco Smoking/adverse effects ; Tobacco Smoking/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva.
Autorzy:: Li JY; Yale University School of Medicine, New Haven, CT, USA. .
Arkfeld CK; Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA.
Tymon-Rosario J; Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA.
Webster E; Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA.
Schwartz P; Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA.
Damast S; Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA.
Menderes G; Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA.; Pokaż więcej
Źródło:: Journal of gynecologic oncology [J Gynecol Oncol] 2022 Mar; Vol. 33 (2), pp. e13. Date of Electronic Publication: 2021 Nov 30.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Squamous Cell*/pathology
Vulvar Neoplasms*/pathology
Disease-Free Survival ; Female ; Humans ; Margins of Excision ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Prognosis ; Retrospective Studies ; Vulva/pathology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Hypoxic gene expression is a prognostic factor for disease free survival in a cohort of locally advanced squamous cell cancer of the uterine cervix.
Autorzy:: Alsner J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
Overgaard J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
Tramm T; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
Lindegaard JC; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.; Pokaż więcej
Źródło:: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 Feb; Vol. 61 (2), pp. 172-178. Date of Electronic Publication: 2021 Sep 29.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/pathology
Carcinoma, Squamous Cell*/therapy
Uterine Cervical Neoplasms*/genetics
Uterine Cervical Neoplasms*/pathology
Uterine Cervical Neoplasms*/therapy
Disease-Free Survival ; Epithelial Cells/pathology ; Female ; Gene Expression ; Humans ; Hypoxia/genetics ; Neoplasm Staging ; Prognosis ; Prospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Radiomics model of 18F-FDG PET/CT imaging for predicting disease-free survival of early-stage uterine cervical squamous cancer.
Autorzy:: Liu S; Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Center for Biomedical Imaging, Fudan University, Shanghai, China.; Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, China.; Key Laboratory of Nuclear Physics and Ion-beam Application, Fudan University, Shanghai, China.; Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
Li R; Department of Automation, Institute of Image Processing and Pattern Recognition, Shanghai Jiao Tong University, Shanghai, China.; Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
Liu Q; Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Center for Biomedical Imaging, Fudan University, Shanghai, China.; Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, China.; Key Laboratory of Nuclear Physics and Ion-beam Application, Fudan University, Shanghai, China.
Sun D; Department of Automation, Institute of Image Processing and Pattern Recognition, Shanghai Jiao Tong University, Shanghai, China.
Yang H; Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Center for Biomedical Imaging, Fudan University, Shanghai, China.; Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, China.; Key Laboratory of Nuclear Physics and Ion-beam Application, Fudan University, Shanghai, China.
Pan H; Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Center for Biomedical Imaging, Fudan University, Shanghai, China.; Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, China.; Key Laboratory of Nuclear Physics and Ion-beam Application, Fudan University, Shanghai, China.
Wang L; SJTU-USYD Joint Research Alliance for Translational Medicine, Shanghai China.; Department of Automation, Institute of Image Processing and Pattern Recognition, Shanghai Jiao Tong University, Shanghai, China.
Song S; Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Center for Biomedical Imaging, Fudan University, Shanghai, China.; Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, China.; Key Laboratory of Nuclear Physics and Ion-beam Application, Fudan University, Shanghai, China.; Pokaż więcej
Źródło:: Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2022; Vol. 33 (2), pp. 249-259.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Carcinoma, Squamous Cell/*diagnostic imaging
Positron Emission Tomography Computed Tomography/*methods
Uterine Cervical Neoplasms/*diagnostic imaging
Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/surgery ; Disease-Free Survival ; Female ; Fluorodeoxyglucose F18 ; Humans ; Middle Aged ; Prognosis ; Radiographic Image Interpretation, Computer-Assisted ; Radiopharmaceuticals ; Uterine Cervical Neoplasms/pathology ; Uterine Cervical Neoplasms/surgery

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
Autorzy:: Sun Y; Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China.
Wang S; Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China.
Zhang X; Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China.
Wu Z; Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China.
Li Z; Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China.
Ding Z; Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China.
Huang X; Department of Oral Pathology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China.
Chen S; Department of Oral Pathology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China.
Jing Y; Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China.
Zhang X; Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China.
Ding L; Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China.
Song Y; Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China.
Sun G; Department of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China.
Ni Y; Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China.; Pokaż więcej
Źródło:: Biomolecules [Biomolecules] 2021 Dec 07; Vol. 11 (12). Date of Electronic Publication: 2021 Dec 07.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Up-Regulation*
Carcinoma, Squamous Cell/*pathology
Lysine/*metabolism
Mouth Neoplasms/*pathology
Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase/*genetics
Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase/*metabolism
Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Carcinoma, Squamous Cell/genetics ; Carcinoma, Squamous Cell/metabolism ; Cell Line, Tumor ; Disease-Free Survival ; Epithelial-Mesenchymal Transition ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Lymphatic Metastasis ; Male ; Mass Spectrometry ; Mouth Neoplasms/genetics ; Mouth Neoplasms/metabolism ; Neoplasm Staging ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: ER expression associates with poor prognosis in male lung squamous carcinoma after radical resection.
Autorzy:: Yang X; Department of Medical Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, Shandong, China.
Jin X; Department of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266003, Shandong, China.
Xu R; Department of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266003, Shandong, China.
Yu Z; Department of Medical Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, Shandong, China.
An N; Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, Shandong, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2021 Sep 21; Vol. 21 (1), pp. 1043. Date of Electronic Publication: 2021 Sep 21.
Typ publikacji:: Journal Article
MeSH Terms:: Gene Expression*
Genes, Neoplasm*
Carcinoma, Squamous Cell/*genetics
Estrogen Receptor alpha/*genetics
Lung Neoplasms/*genetics
Aged ; Algorithms ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/surgery ; Databases, Genetic ; Disease-Free Survival ; Estrogen Receptor beta/genetics ; Genetic Markers ; Humans ; Immunohistochemistry ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Lung Neoplasms/surgery ; Male ; Middle Aged ; Prognosis ; Receptors, Androgen/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.
Autorzy:: Takahashi H; Department of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan. .
Kawabata-Iwakawa R; Division of Integrated Oncology Research, Gunma University Initiative for Advanced Research, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.
Ida S; Department of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.
Mito I; Department of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.
Tada H; Department of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.
Chikamatsu K; Department of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Sep 07; Vol. 11 (1), pp. 17789. Date of Electronic Publication: 2021 Sep 07.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Squamous Cell/*metabolism
Glycolysis/*genetics
Head and Neck Neoplasms/*metabolism
Immune Evasion/*genetics
Squamous Cell Carcinoma of Head and Neck/*metabolism
Antigen Presentation ; B-Lymphocyte Subsets/immunology ; Carcinoma, Squamous Cell/genetics ; Carcinoma, Squamous Cell/immunology ; Carcinoma, Squamous Cell/virology ; Dendritic Cells/immunology ; Disease Progression ; Disease-Free Survival ; Gene Expression Regulation, Neoplastic ; Glycolysis/immunology ; Head and Neck Neoplasms/genetics ; Head and Neck Neoplasms/immunology ; Head and Neck Neoplasms/virology ; Humans ; Kaplan-Meier Estimate ; Lymphocytes, Tumor-Infiltrating/immunology ; Neoplasm Proteins/biosynthesis ; Neoplasm Proteins/genetics ; Papillomaviridae/isolation & purification ; Papillomavirus Infections/genetics ; Papillomavirus Infections/immunology ; Papillomavirus Infections/metabolism ; Prognosis ; RNA, Messenger/biosynthesis ; RNA, Messenger/genetics ; RNA, Neoplasm/biosynthesis ; RNA, Neoplasm/genetics ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/immunology ; Squamous Cell Carcinoma of Head and Neck/virology ; T-Lymphocyte Subsets/immunology ; Transcriptome ; Tumor Microenvironment ; Up-Regulation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Long-term survival outcomes after primary transoral robotic surgery (TORS) with concurrent neck dissection for early-stage oropharyngeal squamous cell carcinoma.
Autorzy:: Frederiksen JG; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Channir HI; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Larsen MHH; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Christensen A; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Friborg J; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Charabi BW; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Rubek N; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
von Buchwald C; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Pokaż więcej
Źródło:: Acta oto-laryngologica [Acta Otolaryngol] 2021 Jul; Vol. 141 (7), pp. 714-718. Date of Electronic Publication: 2021 Jun 30.
Typ publikacji:: Journal Article
MeSH Terms:: Neck Dissection*
Robotic Surgical Procedures*/methods
Carcinoma, Squamous Cell/*surgery
Oropharyngeal Neoplasms/*surgery
Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/therapy ; Combined Modality Therapy ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Male ; Margins of Excision ; Middle Aged ; Neoplasm Recurrence, Local/epidemiology ; Oropharyngeal Neoplasms/mortality ; Oropharyngeal Neoplasms/therapy ; Retrospective Studies ; Survival Analysis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Pulmonary microinvasive small cell carcinoma with an extensive in-situ component identified after photodynamic therapy for 'squamous cell carcinoma in situ': a case report.
Autorzy:: Ota M; Department of Diagnostic Pathology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Nakatani Y; Department of Pathology, Yokosuka Kyosai Hospital, Yokosuka, Japan.
Nakajima T; Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Hiroshima K; Department of Pathology, Tokyo Women's Medical University, Yachiyo Medical Center, Yachiyo, Japan.
Motoi N; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
Yoshino I; Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Ikeda JI; Department of Diagnostic Pathology, Graduate School of Medicine, Chiba University, Chiba, Japan.; Pokaż więcej
Źródło:: Histopathology [Histopathology] 2021 May; Vol. 78 (6), pp. 912-916. Date of Electronic Publication: 2021 Mar 05.
Typ publikacji:: Case Reports; Letter
MeSH Terms:: Photochemotherapy*
Antineoplastic Agents/*therapeutic use
Carcinoma in Situ/*diagnosis
Carcinoma, Squamous Cell/*drug therapy
Lung Neoplasms/*diagnosis
Small Cell Lung Carcinoma/*diagnosis
Aged ; Bronchoscopy ; Carcinoma in Situ/pathology ; Carcinoma in Situ/therapy ; Chemoradiotherapy, Adjuvant ; Cisplatin/therapeutic use ; Disease-Free Survival ; Etoposide/therapeutic use ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/pathology ; Male ; Small Cell Lung Carcinoma/drug therapy ; Small Cell Lung Carcinoma/pathology

Raport

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples.
Autorzy:: Kriegsmann K; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Zgorzelski C; Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, Heidelberg, Germany.
Muley T; Translational Lung Research Centre Heidelberg, Member of the German Centre for Lung Research (DZL), Heidelberg, Germany.; Translational Research Unit, Thoraxklinik at Heidelberg University, Heidelberg, Germany.
Christopoulos P; Translational Research Unit, Thoraxklinik at Heidelberg University, Heidelberg, Germany.; Department of Thoracic Oncology, Thoraxklinik at Heidelberg University, Heidelberg, Germany.
Thomas M; Department of Thoracic Oncology, Thoraxklinik at Heidelberg University, Heidelberg, Germany.
Winter H; Translational Lung Research Centre Heidelberg, Member of the German Centre for Lung Research (DZL), Heidelberg, Germany.; Translational Research Unit, Thoraxklinik at Heidelberg University, Heidelberg, Germany.; Department of Thoracic Surgery, Thoraxklinik at Heidelberg University, Heidelberg, Germany.
Eichhorn M; Translational Lung Research Centre Heidelberg, Member of the German Centre for Lung Research (DZL), Heidelberg, Germany.; Translational Research Unit, Thoraxklinik at Heidelberg University, Heidelberg, Germany.; Department of Thoracic Surgery, Thoraxklinik at Heidelberg University, Heidelberg, Germany.
Eichhorn F; Translational Lung Research Centre Heidelberg, Member of the German Centre for Lung Research (DZL), Heidelberg, Germany.; Translational Research Unit, Thoraxklinik at Heidelberg University, Heidelberg, Germany.; Department of Thoracic Surgery, Thoraxklinik at Heidelberg University, Heidelberg, Germany.
von Winterfeld M; Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, Heidelberg, Germany.
Herpel E; Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, Heidelberg, Germany.
Goeppert B; Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, Heidelberg, Germany.
Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, Heidelberg, Germany.; Translational Lung Research Centre Heidelberg, Member of the German Centre for Lung Research (DZL), Heidelberg, Germany.
Herth FJF; Translational Lung Research Centre Heidelberg, Member of the German Centre for Lung Research (DZL), Heidelberg, Germany.; Department of Pneumology and Critical Care Medicine, Thoraxklinik at Heidelberg University, Heidelberg, Germany.
Warth A; Institute of Pathology, Cytopathology, and Molecular Pathology, UEGP MVZ, Gießen, Wetzlar, Limburg, Germany.
Kriegsmann M; Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, Heidelberg, Germany. .; Translational Lung Research Centre Heidelberg, Member of the German Centre for Lung Research (DZL), Heidelberg, Germany. .; Translational Research Unit, Thoraxklinik at Heidelberg University, Heidelberg, Germany. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2021 May 01; Vol. 21 (1), pp. 486. Date of Electronic Publication: 2021 May 01.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma/*chemistry
CD56 Antigen/*analysis
Carcinoma, Squamous Cell/*chemistry
Chromogranins/*analysis
Lung Neoplasms/*chemistry
Synaptophysin/*analysis
Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adult ; Aged ; Aged, 80 and over ; Analysis of Variance ; Biomarkers, Tumor/analysis ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Cell Differentiation ; Disease-Free Survival ; Female ; Humans ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Retrospective Studies ; Tissue Array Analysis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Clinical significance of tumor-stroma ratio in head and neck cancer: a systematic review and meta-analysis.
Autorzy:: Almangush A; Department of Pathology, University of Helsinki, Haartmaninkatu 3, P.O. Box 21, Helsinki, Finland. .; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. .; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland. .; Institute of Biomedicine, Pathology, University of Turku, Turku, Finland. .; Faculty of Dentistry, Misurata University, Misurata, Libya. .
Alabi RO; Department of Industrial Digitalization, School of Technology and Innovations, University of Vaasa, Vaasa, Finland.
Troiano G; Department of Clinical and Experimental Medicine, Foggia University, Foggia, Italy.
Coletta RD; Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba, São Paulo, Brazil.
Salo T; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.; Department of Pathology, University of Helsinki, Helsinki, Finland.; Cancer and Translational Medicine Research Unit, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.
Pirinen M; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.; Department of Public Health, University of Helsinki, Helsinki, Finland.; Department of Mathematics and Statistics, University of Helsinki, Helsinki, Finland.
Mäkitie AA; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
Leivo I; Institute of Biomedicine, Pathology, University of Turku and Turku University Hospital, Turku, Finland.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2021 Apr 30; Vol. 21 (1), pp. 480. Date of Electronic Publication: 2021 Apr 30.
Typ publikacji:: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:: Carcinoma, Squamous Cell/*pathology
Head and Neck Neoplasms/*pathology
Stromal Cells/*pathology
Carcinoma, Squamous Cell/mortality ; Disease-Free Survival ; Head and Neck Neoplasms/mortality ; Humans ; Laryngeal Neoplasms/mortality ; Laryngeal Neoplasms/pathology ; Nasopharyngeal Neoplasms/mortality ; Nasopharyngeal Neoplasms/pathology ; Pharyngeal Neoplasms/mortality ; Pharyngeal Neoplasms/pathology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Disease-Free Survival"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język